Consider Ingrezza When Treatment Is Needed for Tardive Dyskinesia

The approval of Ingrezza (in-GREH-zah, valbenazine) will raise questions about how to treat tardive dyskinesia.

Up to 30% of patients on long-term antipsychotics develop tardive dyskinesia...involuntary lip smacking, facial grimaces, etc.

It's usually associated with higher doses, longer duration, and higher-potency typical antipsychotics, such as haloperidol.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote